Trainer Phil Serpe Escalates Legal Battle with HISA and FTC
Table of Contents
Saratoga Springs, NY – August 19, 2025 - Trainer Phil Serpe is intensifying his legal challenge against the horseracing Integrity and Safety Authority (HISA) and the Federal Trade Commission (FTC), seeking to overturn a two-year suspension stemming from a contested clenbuterol positive test. The case centers on Serpe’s assertion that his constitutional right to a jury trial is being violated, and has taken a strategic turn with renewed arguments in federal court.
The Core of the Dispute
Serpe’s suspension originated from a positive test for clenbuterol in a urine sample taken from his trainee, Fast Kimmie, following a victory at Saratoga Race Course on August 10, 2024. The Horseracing Integrity and Welfare Unit (HIWU) arbitrator initially imposed the two-year suspension in July. A key point of contention is that HISA and HIWU did not pursue a monetary fine against Serpe, a departure from their handling of twelve other clenbuterol cases since the Anti-Doping and medication Control Program (ADMC) began in May 2023.
Serpe argues that the decision to forgo a fine was a intentional tactic to prevent his case from being heard in federal court, where he believes he is entitled to a jury trial under the Seventh Amendment of the U.S. Constitution. He contends that federal regulations require civil monetary penalties to be litigated in federal court, and that HISA and HIWU intentionally avoided a fine to circumvent this requirement.
Did You Know? Clenbuterol, while approved for certain veterinary uses, is classified as a banned substance in HISA-regulated Thoroughbred racing, meaning it should never be present in a horse’s system.
Legal Arguments and Responses
In a July 15 filing in U.S. District Court (southern District of Florida), Serpe cited a Supreme Court precedent establishing that federal agencies pursuing civil monetary penalties must do so in federal court.He accused HISA and HIWU of “gamesmanship” by strategically avoiding a fine to deny him his right to a jury trial.
Both HISA and the FTC responded on August 15, opposing Serpe’s motion for a preliminary injunction. They maintained that the absence of a fine renders his Seventh Amendment claim invalid.HISA argued that they simply followed the court’s suggested path to resolve the constitutional challenge, while the FTC asserted that without a potential fine, there is no basis for a Seventh Amendment violation.
The agencies also questioned the timing of Serpe’s concerns, noting that he waited eight months after the initial positive test and on the brink of arbitration before raising the issue of the potential fine.They emphasized that their decision not to pursue a fine did not invalidate the underlying violation.
Financial Penalties and Precedent
According to HIWU records, twelve of the fifteen other clenbuterol adjudications as the ADMC’s implementation resulted in fines of at least $15,000. two cases were withdrawn, and one was dropped due to a negative split sample.ADMC Rule 3223 allows for fines of up to $25,000 in cases like Serpe’s.
| Case Element | Details |
|---|---|
| Trainer | Phil Serpe |
| Horse | Fast kimmie |
| Positive Test Substance | Clenbuterol |
| Date of Positive Test | August 10, 2024 |
| Suspension Length | Two Years |
| Potential Fine | Up to $25,000 |
Serpe’s legal team argued during arbitration that a fine was mandatory if liability was found without a finding of no fault or negligence on the trainer’s part.However, HISA countered that Rule 3223(b) does not establish a minimum fine, unlike other sanctions.
Pro Tip: Understanding the specific rules and regulations of the ADMC is crucial for horse trainers and owners to ensure compliance and avoid potential penalties.
Looking Ahead
The case raises important questions about the balance between regulatory authority, constitutional rights, and due process in horse racing. What implications could this case have for future ADMC violations and the enforcement of HISA regulations? Will the court side with Serpe’s claim of constitutional violation, or will it uphold HISA and the FTC’s actions?
The legal battle is ongoing, with the court now considering arguments from both sides. The outcome could have critically important ramifications for the future of horse racing regulation and the rights of trainers facing disciplinary action.
The use of clenbuterol in horse racing has been a contentious issue for decades.Initially regulated due to its potential for abuse as a muscle-building agent, the drug remains a subject of scrutiny and debate. The establishment of HISA and the ADMC represent a significant effort to standardize and strengthen anti-doping regulations across the industry, but challenges to these regulations, like the one presented by Phil Serpe, are certain as stakeholders navigate the new landscape.
Frequently Asked Questions about the Phil Serpe Case
- What is clenbuterol and why is it banned in horse racing? Clenbuterol is a bronchodilator that can also have anabolic effects, leading to its prohibition in racing to ensure fair competition.
- What is HISA and what is its role in regulating horse racing? the Horseracing Integrity and Safety Authority is a national institution established to create uniform standards for horse racing safety and integrity.
- What is the Seventh Amendment and how does it relate to this case? The Seventh Amendment guarantees the right to a jury trial in civil cases, and Serpe argues that HISA and HIWU intentionally avoided a fine to deny him this right.
- What is the ADMC and what are its rules regarding clenbuterol? The Anti-Doping and Medication Control Program sets the rules for medication and doping in HISA-regulated racing, classifying clenbuterol as a banned substance.
- What is the potential outcome of this case? The court could uphold HISA’s decision, overturn the suspension, or order further proceedings.
We encourage you to share this article with your network and join the conversation in the comments below. Subscribe to our newsletter for the latest updates on this developing story and other critically important news in the world of horse racing.